JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB144763

(R)-(+)-Etomoxir, CPT1 inhibitor

Be the first to review this product! Submit a review

|

(2 Publications)

MW 326.8 Da, Purity >98%. CPT1 inhibitor. Inhibits β-oxidation in mitochondria (IC50 values are 0.1, 1 and 10 μM for human, guinea pig and rat hepatocytes respectively). Putative antidiabetic agent.

Key facts

CAS number

124083-20-1

Purity

>98%

Form

Solid

form

Molecular weight

326.8 Da

Molecular formula

C<sub>1</sub><sub>7</sub>H<sub>2</sub><sub>3</sub>ClO<sub>4</sub>

PubChem

9840324

Nature

Synthetic

Solubility

Soluble in water to 20 mM

Soluble in DMSO to 20 mM (with gentle warming)

Biochemical name

R-(+)-Etomoxir

Biological description

CPT1 inhibitor. Inhibits β-oxidation in mitochondria (IC50 values are 0.1, 1 and 10 μM for human, guinea pig and rat hepatocytes respectively). Putative antidiabetic agent.

Canonical smiles

CCOC(=O)C1(CO1)CCCCCCOC2=CC=C(C=C2)Cl

Isomeric smiles

CCOC(=O)[C@]1(CO1)CCCCCCOC2=CC=C(C=C2)Cl

InChi

InChI=1S/C17H23ClO4/c1-2-20-16(19)17(13-22-17)11-5-3-4-6-12-21-15-9-7-14(18)8-10-15/h7-10H,2-6,11-13H2,1H3/t17-/m1/s1

InChiKey

DZLOHEOHWICNIL-QGZVFWFLSA-N

IUPAC Name

ethyl (2R)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
The product can be stored for up to 12 months

Product protocols

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

Cell metabolism 33:411-423.e4 PubMed33306983

2020

Neutrophils Fuel Effective Immune Responses through Gluconeogenesis and Glycogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Pranvera Sadiku,Joseph A Willson,Eilise M Ryan,David Sammut,Patricia Coelho,Emily R Watts,Robert Grecian,Jason M Young,Martin Bewley,Simone Arienti,Ananda S Mirchandani,Manuel A Sanchez Garcia,Tyler Morrison,Ailing Zhang,Leila Reyes,Tobias Griessler,Privjyot Jheeta,Gordon G Paterson,Christopher J Graham,John P Thomson,Kenneth Baillie,A A Roger Thompson,Jessie-May Morgan,Abel Acosta-Sanchez,Veronica M Dardé,Jordi Duran,Joan J Guinovart,Gio Rodriguez-Blanco,Alex Von Kriegsheim,Richard R Meehan,Massimiliano Mazzone,David H Dockrell,Bart Ghesquiere,Peter Carmeliet,Moira K B Whyte,Sarah R Walmsley

Cancer immunology, immunotherapy : CII 69:1973-1987 PubMed32388677

2020

Activated HIF1α of tumor cells promotes chemoresistance development via recruiting GDF15-producing tumor-associated macrophages in gastric cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Shan Yu,Qian Li,Yiyi Yu,Yuehong Cui,Wei Li,Tianshu Liu,Fenglin Liu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com